Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Medroxyprogesterone - InKine

Drug Profile

Medroxyprogesterone - InKine

Alternative Names: Colirest; Hematrol

Latest Information Update: 17 Sep 2007

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator InKine Pharmaceutical; University of Pennsylvania
  • Class Anti-inflammatories; Antineoplastics; Hormonal replacements; Progesterone congeners; Progestogen-only oral contraceptives
  • Mechanism of Action Interleukin 6 inhibitors; Progesterone receptor agonists; Tumour necrosis factor inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Discontinued Autoimmune haemolytic anaemia; Crohn's disease; Idiopathic thrombocytopenic purpura; Ulcerative colitis

Most Recent Events

  • 04 Oct 2005 InKine Pharmaceutical has been acquired by Salix Pharmaceuticals
  • 01 Sep 2005 No development reported - Phase-II for Crohn's disease in USA (PO)
  • 01 Sep 2005 No development reported - Phase-II for Ulcerative colitis in USA (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top